Since 1995, the AKC Canine Health Foundation (CHF) has funded nearly $8.3 million in canine cancer research. This research has provided breakthroughs in treatment options and diagnosis and has helped scientists study cancer at the cellular level, allowing veterinarians to diagnose cancer earlier and treat it more effectively. CHFfunded research has a broad impact, extending beyond dogs to applications in human cancer diagnosis and treatment.

Current cancer research projects include “Growth Signaling Pathways in the Pathogenesis and Treatment of Canine Cancer” (University of Wisconsin); “Heritable and Sporadic Genetic Lesions in Canine Osteosarcoma” (University of Minnesota); and “Evaluation of Neutrophil Function in Treated Tumor-Bearing Dogs” (University of Tennessee).